Search Results 351-360 of 17625 for Glucocorticoids

1. Corticobasal degeneration (corticobasal syndrome) - Doctors and departments - Mayo Clinic

   Learn about this rare disease that affects brain cells. The disease can make it hard to speak, move and think.

2. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

   Current systemic glucocorticoid therapy except for daily glucocorticoidreplacement for conditions such as adrenal or pituitary insufficiency and topical ...

3. Bone and joint problems associated with diabetes - Mayo Clinic

   If started early, physical therapy can help preserve movement and range of motion in the joint. A healthcare professional may give glucocorticoid injections to ...

4. A Study to Investigate the Effectiveness and Safety of Efgartigimod Ph20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy - Mayo Clinic

   * Glucocorticoid-induced myopathy that the investigator considers the primary cause of muscle weakness or permanent weakness linked to a non-idiopathic ...

5. Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine - Mayo Clinic

   Glucocorticoids; Modafinil; Primidone; St. John's wort; Barbiturates; Phenytoin. Vulnerable populations will be excluded (i.e. prisoners, wards of the state ...

6. A Study Of The Effect, Safety, And Tolerability Of LJPC-501 In Patients With Catecholamine-Resistant Hypotension - Mayo Clinic

   Requires more than 500 mg daily of hydrocortisone or equivalent glucocorticoid medication as a standing dose; Has Raynaud's phenomenon, systemic sclerosis or ...

7. Publications - Diane Donegan, M.D. - Mayo Clinic

   Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of ...

8. A Study Of LJPC-501 In Patients With Catecholamine-Resistant Hypotension - Mayo Clinic

   Require more than 500 mg daily of hydrocortisone or equivalent glucocorticoid medication as a standing dose; Have Raynaud's phenomenon, systemic sclerosis or ...

9. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

10. Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma - Mayo Clinic

    ... glucocorticoids for brain or leptomeningeal metastases; Impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the ...